NCT00002250View on ClinicalTrials.gov

A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Immune Thrombocytopenic Purpura ( ITP )HIV Infections
Interventions
DRUG

CD4-IgG

Trial Locations (1)

941102859

San Francisco Gen Hosp, San Francisco

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00002250 - A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura | Biotech Hunter | Biotech Hunter